Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia

ClinicalTrials.gov ID: NCT04372186

Public ClinicalTrials.gov record NCT04372186. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study (EMPACTA) will a) evaluate the efficacy and safety of tocilizumab (TCZ) compared with a placebo in combination with standard of care (SOC) in hospitalized participants with COVID-19 pneumonia, and b) include an optional long-term extension for eligible participants to explore the long-term sequelae of resolved COVID-19 pneumonia.

Study identification

NCT ID
NCT04372186
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genentech, Inc.
Industry
Enrollment
377 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 14, 2020 (Actual)
Primary completion
Aug 18, 2020 (Actual)
Completion
Sep 22, 2020 (Actual)
Last update posted
Feb 10, 2023

2020

United States locations

U.S. sites
32
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Banner - University Medical Center Phoenix; In-Patient Pharmacy Phoenix Arizona 85006 —
Univ of AZ Coll of Med Tucson Arizona 85724 —
El Centro Regional Medical Center El Centro California 92243 —
eStudySite La Mesa California 91942 —
Highland Hospital Oakland Oakland California 94602 —
St. Joseph'S Hospital Orange California 92563 —
San Leandro Hospital; Inpatient Pharmacy San Leandro California 94578 —
Larkin Community Hospital Palm Springs Campus (Hialeah) Hialeah Florida 33012 —
Miami Veterans Administration Healthcare System - NAVREF Miami Florida 33125 —
University of Miami Pulmonary Miami Florida 33125 —
Larkin Community Hospital South Miami Florida 33143 —
St. Lukes Boise Medical Center Boise Idaho 83712 —
Ochsner Clinic New Orleans Louisiana 70121 —
Holy Cross Germantown Hospital Germantown Maryland 20876 —
Holy Cross Hospital Silver Spring Maryland 20910 —
Henry Ford Health System Detroit Michigan 48202 —
St. Joseph'S Regional Medical Center Paterson New Jersey 07503 —
San Juan Oncology Associates Farmington New Mexico 87401 —
SUNY Downstate Medical Center. Brooklyn New York 11203 —
Elmhurst Hospital Center Elmhurst New York 11373 —
Flushing Hospital Flushing New York 11355 —
Jamaica Hospital Medical Center Jamaica New York 11418 —
Harlem Hospital New York New York 10037 —
Canton-Potsdam Hospital Potsdam New York 13676 —
St. Barnabas Hospital The Bronx New York 10457 —
Novant Health Presbyterian Medical Center (Presbyterian Hospital) Charlotte North Carolina 28204 —
Cape Fear Valley Medical Center Fayetteville North Carolina 28304 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Valley Baptist Medical Center Harlingen Texas 78550 —
Michael E Debakey VA Medical Center Houston Texas 77030 —
McAllen Medical Center McAllen Texas 78503 —
Sentara Medical Group Virginia Beach Virginia 23462 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04372186, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2023 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04372186 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →